1: De Vry J, Rudiger Jentzsch K. Related Articles, Links
Discriminative stimulus effects of BAY 38-7271, a novel cannabinoid receptor agonist.
Eur J Pharmacol. 2002 Dec 20;457(2-3):147-152.
PMID: 12464360 [PubMed - as supplied by publisher]
2: Pertwee RG, Ross RA, Craib SJ, Thomas A. Related Articles, Links
(-)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens.
Eur J Pharmacol. 2002 Dec 5;456(1-3):99-106.
PMID: 12450575 [PubMed - as supplied by publisher]
3: Guhring H, Hamza M, Sergejeva M, Ates M, Kotalla CE, Ledent C, Brune K. Related Articles, Links
A role for endocannabinoids in indomethacin-induced spinal antinociception.
Eur J Pharmacol. 2002 Nov 15;454(2-3):153-63.
PMID: 12421642 [PubMed - in process]
4: Martin RS, Secchi RL, Sung E, Lemaire M, Bonhaus DW, Hedley LR, Lowe DA. Related Articles, Links
Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat.
Psychopharmacology (Berl). 2002 Oct 29 [epub ahead of print]
PMID: 12404071 [PubMed - as supplied by publisher]
5: Cohen C, Perrault G, Voltz C, Steinberg R, Soubrie P. Related Articles, Links
SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats.
Behav Pharmacol. 2002 Sep;13(5-6):451-63.
PMID: 12394421 [PubMed - in process]
Time used: 31 miliseconds.

Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005